Genetic Causes of Hereditary Myopathies in a Cohort of Male Patients: Molecular Diagnosis in Myopathies

The combined use of MLPA and targeted NGS improves the molecular diagnosis of hereditary myopathies. This approach provides insights into the genetic landscape of neuromuscular disorders, enabling better clinical management, genetic counseling, and potential eligibility for emerging therapies.